... MD; AND B. DOUGLAS SMITH, MD 50 Myelodysplastic Syndrome 425 TARA LIN, MD; AND B. DOUGLAS SMITH, MD 51 Blood Smear and Bone Marrow Review 429 JONATHAN M. GERBER, MD SECTION NINE Oncology 437 52 Colorectal Cancer 439 DAVID COSGROVE, ...
Colorectal Cancer 478 DAVID COSGROVE 53. Breast and Ovarian Cancer 483 DEBORAH K. ARMSTRONG 54. Genitourinary Cancer 489 MICHAEL A. CARDUCCI, HANS HAMMERS, and NOAH M. HAHN 55. Lymphoma and Chronic Lymphocytic Leukemia 498 YVETTE L.
Colorectal Cancer 478 DAVID COSGROVE 53. Breast and Ovarian Cancer 483 DEBORAH K. ARMSTRONG 54. Genitourinary Cancer 489 MICHAEL A. CARDUCCI, HANS HAMMERS, and NOAH M. HAHN 55. Lymphoma and Chronic Lymphocytic Leukemia 498 YVETTE L.
Bioterrorism SARA E. COSGROVE, MD, MS The anthrax attacks of 2001, along with the increasing political instability worldwide, have reminded physicians of the importance of being familiar with the clinical features of agents that can be ...
... and factor XIa Quick onset of action (within minutes to hours) Delivered intravenously to treat thromboembolism; may be used subcutaneously (5000 units subcutaneously two or three times daily) for prophylaxis Monitor aPTT ...